Page last updated: 2024-10-28

fasudil and Neointima

fasudil has been researched along with Neointima in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.

Research Excerpts

ExcerptRelevanceReference
"Fasudil‑treated mice developed a significantly smaller intima‑media thickness compared with the untreated mice."1.42Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling. ( Gao, F; Li, Q; Li, W; Li, Y; Shen, C; Zhang, T; Zhang, X, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, X2
Zhang, T1
Gao, F1
Li, Q1
Shen, C1
Li, Y1
Li, W1

Other Studies

1 other study available for fasudil and Neointima

ArticleYear
Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
    Molecular medicine reports, 2015, Volume: 12, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Carotid Arteries; Carotid Intima-Media Thick

2015